Retirement Systems of Alabama boosted its stake in Clorox Co. (NYSE:CLX) by 0.6% during the second quarter, Holdings Channel reports. The fund owned 65,939 shares of the company’s stock after buying an additional 389 shares during the period. Retirement Systems of Alabama’s holdings in Clorox were worth $9,125,000 as of its most recent filing with the SEC.
Other large investors have also recently made changes to their positions in the company. BlackRock Institutional Trust Company N.A. boosted its stake in shares of Clorox by 7.5% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 4,504,422 shares of the company’s stock valued at $567,827,000 after buying an additional 313,224 shares during the last quarter. BlackRock Group LTD boosted its stake in shares of Clorox by 18.2% in the first quarter. BlackRock Group LTD now owns 1,592,689 shares of the company’s stock valued at $200,775,000 after buying an additional 245,650 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Clorox by 2.7% in the first quarter. Geode Capital Management LLC now owns 1,182,810 shares of the company’s stock valued at $148,838,000 after buying an additional 30,881 shares during the last quarter. Legal & General Group Plc boosted its stake in shares of Clorox by 1.7% in the first quarter. Legal & General Group Plc now owns 682,421 shares of the company’s stock valued at $86,041,000 after buying an additional 11,428 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. boosted its stake in shares of Clorox by 4.6% in the second quarter. Robeco Institutional Asset Management B.V. now owns 645,563 shares of the company’s stock valued at $89,335,000 after buying an additional 28,301 shares during the last quarter. 70.21% of the stock is currently owned by hedge funds and other institutional investors.
Clorox Co. (NYSE:CLX) traded down 0.07% during trading on Friday, hitting $122.65. 974,005 shares of the stock traded hands. Clorox Co. has a one year low of $119.23 and a one year high of $140.47. The company’s 50 day moving average is $126.61 and its 200 day moving average is $129.88. The company has a market capitalization of $15.88 billion, a P/E ratio of 24.93 and a beta of 0.29.
Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.28 by $0.02. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The business earned $1.60 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same period in the previous year, the business posted $1.44 earnings per share. Clorox’s revenue was up 2.8% compared to the same quarter last year. On average, equities analysts forecast that Clorox Co. will post $5.49 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be paid a $0.80 dividend. The ex-dividend date of this dividend is Monday, October 24th. This represents a $3.20 dividend on an annualized basis and a yield of 2.61%. Clorox’s payout ratio is presently 64.91%.
Several equities research analysts recently commented on CLX shares. Jefferies Group reissued a “hold” rating on shares of Clorox in a report on Wednesday, August 3rd. B. Riley reaffirmed a “neutral” rating and issued a $109.00 price target on shares of Clorox in a report on Tuesday, August 9th. Atlantic Securities initiated coverage on Clorox in a report on Tuesday, June 14th. They issued a “neutral” rating and a $138.00 price target on the stock. Deutsche Bank AG reaffirmed a “hold” rating and issued a $134.00 price target (up previously from $130.00) on shares of Clorox in a report on Sunday, July 24th. Finally, Zacks Investment Research cut Clorox from a “hold” rating to a “sell” rating in a report on Tuesday, July 5th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. Clorox currently has a consensus rating of “Hold” and a consensus price target of $128.90.
In other Clorox news, EVP Laura Stein sold 38,882 shares of the firm’s stock in a transaction that occurred on Friday, September 2nd. The shares were sold at an average price of $131.69, for a total value of $5,120,370.58. Following the transaction, the executive vice president now directly owns 48,501 shares of the company’s stock, valued at $6,387,096.69. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Dawn C. Willoughby sold 10,617 shares of the firm’s stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $131.01, for a total transaction of $1,390,933.17. Following the completion of the transaction, the chief operating officer now directly owns 20,353 shares in the company, valued at $2,666,446.53. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by company insiders.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.